000 01535 a2200445 4500
005 20250518002037.0
264 0 _c20181023
008 201810s 0 0 eng d
022 _a1536-5964
024 7 _a10.1097/MD.0000000000012518
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDejust, Sebastien
245 0 0 _aEverolimus-induced pulmonary toxicity: Findings on 18F-FDG PET/CT imaging.
_h[electronic resource]
260 _bMedicine
_cOct 2018
300 _ae12518 p.
_bdigital
500 _aPublication Type: Journal Article; Observational Study
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAndrostadienes
_xadministration & dosage
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aEverolimus
_xadverse effects
650 0 4 _aFemale
650 0 4 _aFluorodeoxyglucose F18
650 0 4 _aGlycolysis
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLung Diseases, Interstitial
_xchemically induced
650 0 4 _aMiddle Aged
650 0 4 _aPositron Emission Tomography Computed Tomography
650 0 4 _aTOR Serine-Threonine Kinases
_xantagonists & inhibitors
650 0 4 _aTumor Burden
700 1 _aMorland, David
700 1 _aBruna-Muraille, Claire
700 1 _aEymard, Jean-Christophe
700 1 _aYazbek, Gabriel
700 1 _aSavoye, Aude-Marie
700 1 _aPapathanassiou, Dimitri
773 0 _tMedicine
_gvol. 97
_gno. 40
_gp. e12518
856 4 0 _uhttps://doi.org/10.1097/MD.0000000000012518
_zAvailable from publisher's website
999 _c28909140
_d28909140